The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.00
Bid: 112.00
Ask: 113.00
Change: 0.50 (0.45%)
Spread: 1.00 (0.893%)
Open: 109.50
High: 112.00
Low: 109.50
Prev. Close: 111.50
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JSOP Award

8 Mar 2019 07:00

RNS Number : 2445S
Litigation Capital Management Ltd
08 March 2019
 

8 March 2019

Litigation Capital Management Limited

("LCM" or the "Company")

 

JSOP Award

 

Litigation Capital Management Limited (AIM:LIT), a leading international provider of litigation financing solutions, announces that it is giving effect to the disclosure made in the Admission document dated 13 December 2018 and has today granted executive director, Nick Rowles-Davies (the "Participant"), an interest over 4,347,517 ordinary shares in the Company, representing 3.85% of the enlarged issued share capital of the Company1, pursuant to a joint share ownership plan ("JSOP").

 

These newly issued ordinary shares will be held by the LCM Employee Benefit Trust ("EBT"), which has been established to hold shares under the JSOP ("JSOP Shares"). The beneficial interest in JSOP Shares is jointly held between the relevant participant and the EBT. Under the JSOP rules, it has been agreed that no voting rights will be exercised on the JSOP Shares prior to their vesting date.

 

A limited recourse loan agreement will be entered into between the Company and both the EBT and Mr. Rowles-Davies. The loan for Mr. Rowles-Davies will be for a term of 10 years and an amount of GBP 217,375.85, which represents market value for Mr. Rowles-Davies interest in the JSOP.

 

The JSOP award to Mr. Rowles-Davies will vest on the third anniversary of the 19th December 2018, subject to continued employment and performance conditions including a share price target of a 175 pence being achieved at any time during the vesting period. In addition, the JSOP award is subject to malus and clawback provisions. The award vests in full in the event of a change of control at any time.

 

Pursuant to the JSOP rules, Mr. Rowles-Davies will benefit from the growth in value of each JSOP Share from the LCM share price on Admission of 52 pence subject to the conditions outlined above.

 

The key benefits of the JSOP are: 

· a real interest in shares for the Participant, which encourages strong individual and Company performance by aligning the interests of Mr. Rowles-Davies with those of the Company and other shareholders;

· provided there is a strong expectation of growth, the JSOP structure lends itself well to the Company's commercial proposal of allowing Mr. Rowles-Davies to enjoy the growth in value of up to c. 3.85% of the issued share capital of LCM.

 

As disclosed in the Company's admission document in December 2018, this award does not count towards any limits applying to the New Share Plans.

 

Application will be made for the 4,347,517 ordinary shares to be admitted to trading on AIM. It is expected that admission will take place on 18 March 2019. Following the allotment and issue, the Company's issued share capital consists of 113,035,446 ordinary shares. The Company does not hold any shares in Treasury, as such the total number of shares in issue with voting rights is 113,035,446.

 

The above figure of 113,035,446 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

1 Share capital enlarged for new issue of shares to the EBT.

 

 

 

CONTACTS

 

 

Litigation Capital Management

 

Patrick Moloney, Chief Executive Officer

 

 

 

 

 

Canaccord (Nomad and Broker)

 

Sunil Duggal / Emma Gabriel

Tel: 020 7523 8000

 

 

Hawthorn Advisors

 

Lorna Cobbett / Zinka MacHale

Tel: 020 3745 4960

lcm@hawthornadvisors.com

 

NOTES TO EDITORS

 

About LCM:

Litigation Capital Management ("LCM") is a leading international provider of litigation financing solutions. This includes single-case and portfolios across; class actions, commercial claims, claims arising out of insolvency and international arbitration. LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management. Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

Nick Rowles-Davies

2.

Reason for the notification

a)

Position / status

Executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Litigation Capital Management Limited

b)

Legal Entity Identifier

213800J2B5SI8F515244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Jointly held Ordinary Shares

AU000000LCA6

b)

Nature of the transaction

Interest in Ordinary Shares under a Joint Share Ownership

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 217,375.85

4,347,517 shares

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

N/A - single transaction

e)

Date of the transaction

7 March 2019 (UK)

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHJRMJTMBJMTRL
Date   Source Headline
23rd Aug 20227:00 amRNSNotice of Results
15th Jul 20228:22 amRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSMarket Update
16th May 20227:00 amRNSLitigation Finance Agreement
4th May 202210:15 amRNSDirector/PDMR Shareholding
25th Apr 20229:30 amRNSDirector/PDMR Shareholding
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSInterim Results
14th Mar 202210:30 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSNotice of Results
14th Feb 20227:00 amRNSMary Gangemi Appointed to the Board
7th Feb 202210:30 amRNSDirector/PDMR Shareholding
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
4th Jan 20223:58 pmRNSHolding(s) in Company
29th Dec 20214:10 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSBoard change
10th Dec 202112:30 pmRNSIssue of Equity and Total Voting Rights
18th Nov 20217:00 amRNSResult of AGM
4th Nov 20217:00 amRNSSuccessful Award in LCIA International Arbitration
29th Oct 20211:24 pmRNSExercise of Options, Equity Issue, Director/PDMR
29th Oct 20211:00 pmRNSIncentive Awards
25th Oct 20217:00 amRNSNotice of AGM
18th Oct 202111:15 amRNSIssue of Equity and Total Voting Rights
14th Oct 20217:00 amRNSLCM Global Alternative Returns Fund II
22nd Sep 202111:20 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSFinal Results 2021
31st Aug 20217:00 amRNSNotice of Results
11th Aug 20217:07 amRNSSuccessful judgment in Australian investment
19th Jul 20217:00 amRNSMarket Update
6th Jul 20217:00 amRNSNew Litigation Finance Agreement
23rd Jun 20217:00 amRNSComet Group liquidation claim
21st Jun 20217:21 amRNSJudgment in New Zealand Investment
27th May 20217:00 amRNSInvestor Presentation
19th May 20217:18 amRNSLitigation Finance Agreement with Carillion
4th May 202112:09 pmRNSHolding(s) in Company
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSInterim Results
10th Mar 20216:07 pmRNSIssue of Equity and Total Voting Rights
10th Mar 20215:53 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSRetail Investor Presentation
22nd Feb 20217:00 amRNSNew US$50m Credit Facility
18th Feb 20212:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSNotice of Results
12th Feb 20215:13 pmRNSHolding(s) in Company
7th Jan 202111:20 amRNSHolding(s) in Company
17th Dec 202012:17 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSResult of AGM
28th Oct 20207:00 amRNSNotice of Annual General Meeting
15th Oct 202010:30 amRNSIncentive Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.